FDA Drug Application (202210) for ESCITALOPRAM OXALATE by MACLEODS PHARMS LTD

Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Application Number202210
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameESCITALOPRAM OXALATE
Active IngredientESCITALOPRAM OXALATE

Active IngredientCount
List of drugs with Active Ingredient ESCITALOPRAM OXALATE3


Back to FDA Applications sponsored by MACLEODS PHARMS LTD